THE RNA SOCIETY
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$3,776,463
Investments
77%
Cash & Equivalents
15%
Prepaid Expenses
6%
Receivables (Non-Related)
3%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$181,970
Deferred Revenue
86%
Payables & Accruals
14%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$376,510
$552,557
+47%
Receivables (Non-Related)
$181,814
$98,802
-46%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$270,812
$210,954
-22%
Investments
$2,848,869
$2,914,150
+2%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$3,678,005
$3,776,463
+3%
Liabilities
2023
2024
Change
Payables & Accruals
$13,412
$25,907
+93%
Grants Payable
-
-
-
Deferred Revenue
$180,469
$156,063
-14%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$193,881
$181,970
-6%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$3,484,124
$3,594,493
+3%
Net assets
2023
2024
Change
Net assets
+$3,484,124
+$3,594,493
+3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)